Parent-Reported Symptom Assessments in Children Taking Multiple Medications

CompletedOBSERVATIONAL
Enrollment

136

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Neurologic DisorderChronic DiseasePediatric Disorder
Interventions
OTHER

Parent-Reported Symptom Assessment

As the basis for PRSA, the investigator will use the PediQuest Memorial Symptom Assessment Scale (PQ-MSAS), which is an adapted pediatric-specific version of the validated adult MSAS that assesses 28 physical and psychological symptoms over the past week. The study instrument is designed to be completed by a full-proxy parent, and 2 versions tailored for specific age groups are available (0-3, 3-18 years-old). Spanish versions are available for both instruments. The PQ-MSAS contains 28 symptom items, each with 4-point scores for domains of frequency, severity, and extent of bother. Based on these components, a global symptom score and individual symptom scores can be calculated (0-100 scale, with 100 being the worst).

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Colorado, Denver

OTHER

NCT03849066 - Parent-Reported Symptom Assessments in Children Taking Multiple Medications | Biotech Hunter | Biotech Hunter